Sivik Global Healthcare LLC lessened its stake in shares of Agilent Technologies Inc (NYSE:A) by 4.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,000 shares of the medical research company’s stock after selling 2,148 shares during the period. Sivik Global Healthcare LLC’s holdings in Agilent Technologies were worth $3,617,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of A. US Bancorp DE increased its stake in shares of Agilent Technologies by 1.1% in the 1st quarter. US Bancorp DE now owns 91,762 shares of the medical research company’s stock valued at $7,377,000 after purchasing an additional 1,030 shares during the last quarter. Greenleaf Trust increased its stake in shares of Agilent Technologies by 8.8% in the 1st quarter. Greenleaf Trust now owns 3,290 shares of the medical research company’s stock valued at $264,000 after purchasing an additional 265 shares during the last quarter. Keybank National Association OH increased its stake in shares of Agilent Technologies by 374.3% in the 1st quarter. Keybank National Association OH now owns 60,101 shares of the medical research company’s stock valued at $4,831,000 after purchasing an additional 47,429 shares during the last quarter. FormulaFolio Investments LLC bought a new position in shares of Agilent Technologies in the 1st quarter valued at $280,000. Finally, TD Asset Management Inc. increased its stake in shares of Agilent Technologies by 12.1% in the 1st quarter. TD Asset Management Inc. now owns 740,755 shares of the medical research company’s stock valued at $59,542,000 after purchasing an additional 80,064 shares during the last quarter.

A has been the topic of a number of research reports. UBS Group initiated coverage on Agilent Technologies in a research report on Friday, March 15th. They set a “buy” rating and a $92.00 price objective on the stock. JPMorgan Chase & Co. boosted their price objective on Agilent Technologies to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, February 21st. Bank of America restated a “buy” rating and set a $87.00 price objective (up previously from $78.00) on shares of Agilent Technologies in a research report on Thursday, February 21st. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $88.00 price objective on the stock in a research report on Friday, February 22nd. Finally, Needham & Company LLC restated a “buy” rating and set a $88.00 price objective (up previously from $77.00) on shares of Agilent Technologies in a research report on Monday, February 25th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $86.58.

Shares of A opened at $68.55 on Wednesday. The stock has a market cap of $21.77 billion, a price-to-earnings ratio of 24.57, a P/E/G ratio of 1.93 and a beta of 1.33. Agilent Technologies Inc has a 12 month low of $60.42 and a 12 month high of $82.27. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.79 and a current ratio of 3.41.

Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.65 earnings per share. On average, equities research analysts forecast that Agilent Technologies Inc will post 3.05 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd were issued a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend was Monday, April 1st. Agilent Technologies’s payout ratio is presently 23.66%.

In other Agilent Technologies news, VP Rodney Gonsalves sold 6,155 shares of Agilent Technologies stock in a transaction dated Wednesday, March 6th. The stock was sold at an average price of $79.79, for a total transaction of $491,107.45. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Mark Doak sold 16,421 shares of Agilent Technologies stock in a transaction dated Friday, February 22nd. The stock was sold at an average price of $77.95, for a total value of $1,280,016.95. The disclosure for this sale can be found here. Insiders have sold a total of 48,583 shares of company stock worth $3,855,924 over the last ninety days.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://theolympiareport.com/2019/05/22/sivik-global-healthcare-llc-sells-2148-shares-of-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: How Investors Use a Balance Sheet

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.